Tokyo company acquires KC Specialty Therapeutics

Hungry for expansion opportunities in the U.S., a Tokyo-based company is acquiring the assets of KC Specialty Therapeutics in Kansas City, Kan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.